Related references
Note: Only part of the references are listed.Percutaneous transluminal septal myocardial ablation: past, present, and future
Yuichiro Maekawa et al.
JOURNAL OF CARDIOLOGY (2022)
The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy
Jae-Man Lee et al.
PLOS ONE (2022)
Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation
Takenori Ikoma et al.
PLOS ONE (2022)
Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy
Toru Kubo et al.
ESC HEART FAILURE (2022)
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Hiroaki Kitaoka et al.
CIRCULATION JOURNAL (2021)
Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy
Toru Kubo et al.
ESC HEART FAILURE (2021)
Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction Insights From the SHaRe Registry
Peter Marstrand et al.
CIRCULATION (2020)
The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy
Yishay Wasserstrum et al.
EUROPEAN HEART JOURNAL (2019)
Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis
Josef Veselka et al.
EUROPEAN HEART JOURNAL (2019)
Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes
Carey Kimmelstiel et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy
Yoshiyasu Aizawa et al.
KEIO JOURNAL OF MEDICINE (2019)
Patients' Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study
Toru Kubo et al.
CIRCULATION JOURNAL (2018)
Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance
Yasuo Amano et al.
MAGNETIC RESONANCE IN MEDICAL SCIENCES (2018)
Clinical Course and Management of Hypertrophic Cardiomyopathy
Barry J. Maron
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
Kyoung-min Park et al.
PLOS ONE (2016)
Patterns of Disease Progression in Hypertrophic Cardiomyopathy An Individualized Approach to Clinical Staging
Iacopo Olivotto et al.
CIRCULATION-HEART FAILURE (2012)
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Dilated-hypokinetic evolution of hypertrophic cardiomyopathy - Prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients
E Biagini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
AS Levey et al.
KIDNEY INTERNATIONAL (2005)
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients
L Monserrat et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)